Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-18

Clinical Trial Update: Wound Infiltration of Liposomal Bupivacaine v Plain Bupivacaine for Post-Op Pain Control in Elective Cesarean Delivery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing wound infiltration of liposomal bupivacaine versus plain bupivacaine for post-operative pain control after elective cesarean delivery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Brooke Army Medical Center | Conditions: Bupivacaine, Pain, Postoperative | Phase 4 | Status: UNKNOWN